InvestorsHub Logo
Followers 62
Posts 7548
Boards Moderated 1
Alias Born 01/02/2003

Re: Jasbg post# 406674

Sunday, 04/02/2023 7:22:37 AM

Sunday, April 02, 2023 7:22:37 AM

Post# of 425916
A one product biotech can be sold on a concept only...It can be sold on a successful phase one study...It can be sold on a phase two...or phase three study...it can be sold with a product already being successfully marketed...It SHOULD be sold...and SHOULD NOT GIA IMO with a product now being challenged by generics in the U.S.
.

The continuing policy of former Amarin management to GIA seemed, at least to me, to have been a misguided policy... and a change in management seemed in order.

My hope is that Denner will work to get share price up, followed by a sale of he company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News